Annual Working Capital
$6.30 M
-$23.33 M-78.72%
December 31, 2023
Summary
- As of February 7, 2025, TCRT annual working capital is $6.30 million, with the most recent change of -$23.33 million (-78.72%) on December 31, 2023.
- During the last 3 years, TCRT annual working capital has fallen by -$105.92 million (-94.38%).
- TCRT annual working capital is now -95.31% below its all-time high of $134.40 million, reached on December 31, 2015.
Performance
TCRT Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$2.72 M
-$1.05 M-27.76%
September 30, 2024
Summary
- As of February 7, 2025, TCRT quarterly working capital is $2.72 million, with the most recent change of -$1.05 million (-27.76%) on September 30, 2024.
- Over the past year, TCRT quarterly working capital has dropped by -$1.05 million (-27.76%).
- TCRT quarterly working capital is now -98.44% below its all-time high of $175.04 million, reached on March 31, 2020.
Performance
TCRT Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
TCRT Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -78.7% | -27.8% |
| 3 y3 years | -94.4% | -96.0% |
| 5 y5 years | -91.6% | -98.0% |
TCRT Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -90.0% | at low | -95.7% | at low |
| 5 y | 5-year | -94.4% | at low | -98.4% | at low |
| alltime | all time | -95.3% | +1516.5% | -98.4% | +120.9% |
Alaunos Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.72 M(-27.8%) |
| Jun 2024 | - | $3.77 M(-21.4%) |
| Mar 2024 | - | $4.80 M(-23.9%) |
| Dec 2023 | $6.30 M(-78.7%) | $6.30 M(-23.0%) |
| Sep 2023 | - | $8.19 M(-40.3%) |
| Jun 2023 | - | $13.73 M(-35.0%) |
| Mar 2023 | - | $21.12 M(-28.7%) |
| Dec 2022 | $29.63 M(-52.8%) | $29.63 M(+30.9%) |
| Sep 2022 | - | $22.64 M(-34.6%) |
| Jun 2022 | - | $34.59 M(-28.7%) |
| Mar 2022 | - | $48.54 M(-22.7%) |
| Dec 2021 | $62.79 M(-44.0%) | $62.79 M(-8.2%) |
| Sep 2021 | - | $68.38 M(-9.8%) |
| Jun 2021 | - | $75.81 M(-19.1%) |
| Mar 2021 | - | $93.75 M(-16.5%) |
| Dec 2020 | $112.22 M(+20.7%) | $112.22 M(-17.3%) |
| Sep 2020 | - | $135.75 M(-13.0%) |
| Jun 2020 | - | $156.06 M(-10.8%) |
| Mar 2020 | - | $175.04 M(+88.3%) |
| Dec 2019 | $92.97 M(+24.3%) | $92.97 M(-11.0%) |
| Sep 2019 | - | $104.42 M(+88.3%) |
| Jun 2019 | - | $55.46 M(-15.7%) |
| Mar 2019 | - | $65.75 M(-12.1%) |
| Dec 2018 | $74.80 M(+7.0%) | $74.80 M(-674.4%) |
| Sep 2018 | - | -$13.02 M(-129.8%) |
| Jun 2018 | - | $43.68 M(-29.6%) |
| Mar 2018 | - | $62.05 M(-11.3%) |
| Dec 2017 | $69.93 M(-21.5%) | $69.93 M(-27.7%) |
| Sep 2017 | - | $96.70 M(-11.4%) |
| Jun 2017 | - | $109.14 M(+45.0%) |
| Mar 2017 | - | $75.29 M(-15.5%) |
| Dec 2016 | $89.08 M(-33.7%) | $89.08 M(-10.9%) |
| Sep 2016 | - | $99.93 M(-9.7%) |
| Jun 2016 | - | $110.67 M(-10.1%) |
| Mar 2016 | - | $123.11 M(-8.4%) |
| Dec 2015 | $134.40 M(+304.1%) | $134.40 M(-5.9%) |
| Sep 2015 | - | $142.85 M(+29.9%) |
| Jun 2015 | - | $109.97 M(-8.4%) |
| Mar 2015 | - | $120.11 M(+261.1%) |
| Dec 2014 | $33.26 M(-46.8%) | $33.26 M(-7.9%) |
| Sep 2014 | - | $36.11 M(-16.5%) |
| Jun 2014 | - | $43.24 M(-20.9%) |
| Mar 2014 | - | $54.65 M(-12.6%) |
| Dec 2013 | $62.51 M(+1.8%) | $62.51 M(+349.3%) |
| Sep 2013 | - | $13.91 M(-36.9%) |
| Jun 2013 | - | $22.03 M(-45.2%) |
| Mar 2013 | - | $40.20 M(-34.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $61.41 M(-33.8%) | $61.41 M(-24.0%) |
| Sep 2012 | - | $80.84 M(-20.5%) |
| Jun 2012 | - | $101.67 M(-18.3%) |
| Mar 2012 | - | $124.48 M(+34.2%) |
| Dec 2011 | $92.74 M(+62.1%) | $92.74 M(-14.6%) |
| Sep 2011 | - | $108.65 M(-11.4%) |
| Jun 2011 | - | $122.61 M(-0.7%) |
| Mar 2011 | - | $123.43 M(+115.8%) |
| Dec 2010 | $57.20 M(+24.1%) | $57.20 M(-8.8%) |
| Sep 2010 | - | $62.72 M(-12.5%) |
| Jun 2010 | - | $71.64 M(+68.5%) |
| Mar 2010 | - | $42.52 M(-7.8%) |
| Dec 2009 | $46.10 M(+677.4%) | $46.10 M(+1071.2%) |
| Sep 2009 | - | $3.94 M(+198.0%) |
| Jun 2009 | - | $1.32 M(-56.7%) |
| Mar 2009 | - | $3.05 M(-48.6%) |
| Dec 2008 | $5.93 M(-79.7%) | $5.93 M(-41.1%) |
| Sep 2008 | - | $10.07 M(-33.5%) |
| Jun 2008 | - | $15.14 M(-28.2%) |
| Mar 2008 | - | $21.09 M(-27.8%) |
| Dec 2007 | $29.22 M(+12.7%) | $29.22 M(-20.1%) |
| Sep 2007 | - | $36.56 M(-16.3%) |
| Jun 2007 | - | $43.68 M(-12.5%) |
| Mar 2007 | - | $49.92 M(+92.5%) |
| Dec 2006 | $25.94 M(+279.3%) | $25.94 M(-17.8%) |
| Sep 2006 | - | $31.53 M(-9.2%) |
| Jun 2006 | - | $34.71 M(+792.9%) |
| Mar 2006 | - | $3.89 M(-43.1%) |
| Dec 2005 | $6.84 M(-1636.2%) | $6.84 M(-25.7%) |
| Sep 2005 | - | $9.20 M(<-9900.0%) |
| Jun 2005 | - | -$8800.00(-49.7%) |
| Mar 2005 | - | -$17.50 K(-96.1%) |
| Dec 2004 | -$445.10 K(+1631.9%) | -$445.10 K(+2887.2%) |
| Sep 2004 | - | -$14.90 K(+9.6%) |
| Jun 2004 | - | -$13.60 K(-37.6%) |
| Mar 2004 | - | -$21.80 K(-15.2%) |
| Dec 2003 | -$25.70 K(+44.4%) | -$25.70 K(+33.2%) |
| Sep 2003 | - | -$19.30 K(+27.0%) |
| Jun 2003 | - | -$15.20 K(+16.9%) |
| Mar 2003 | - | -$13.00 K(-27.0%) |
| Dec 2002 | -$17.80 K(+256.0%) | -$17.80 K(+287.0%) |
| Sep 2002 | - | -$4600.00(-39.5%) |
| Jun 2002 | - | -$7600.00(-7700.0%) |
| Mar 2002 | - | $100.00(-102.0%) |
| Dec 2001 | -$5000.00 | -$5000.00(-2.0%) |
| Sep 2001 | - | -$5100.00(+240.0%) |
| Jun 2001 | - | -$1500.00 |
FAQ
- What is Alaunos Therapeutics annual working capital?
- What is the all time high annual working capital for Alaunos Therapeutics?
- What is Alaunos Therapeutics annual working capital year-on-year change?
- What is Alaunos Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Alaunos Therapeutics?
- What is Alaunos Therapeutics quarterly working capital year-on-year change?
What is Alaunos Therapeutics annual working capital?
The current annual working capital of TCRT is $6.30 M
What is the all time high annual working capital for Alaunos Therapeutics?
Alaunos Therapeutics all-time high annual working capital is $134.40 M
What is Alaunos Therapeutics annual working capital year-on-year change?
Over the past year, TCRT annual working capital has changed by -$23.33 M (-78.72%)
What is Alaunos Therapeutics quarterly working capital?
The current quarterly working capital of TCRT is $2.72 M
What is the all time high quarterly working capital for Alaunos Therapeutics?
Alaunos Therapeutics all-time high quarterly working capital is $175.04 M
What is Alaunos Therapeutics quarterly working capital year-on-year change?
Over the past year, TCRT quarterly working capital has changed by -$1.05 M (-27.76%)